The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma

Teiji Kuzuya; Masatoshi Ishigami; Takurou Niinomi; Norihiro Imai; Kouichi Achiwa; Takahiro Arakawa; Keiichi Yamada; Satoshi Nakano; Yoji Ishizu; Takashi Honda; Kazuhiko Hayashi; Tetsuya Ishikawa; Isao Nakano; Yoshiaki Katano; Akihiro Itoh; Yoshiki Hirooka; Hidemi Goto

doi:10.2957/kanzo.54.505

The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma

Teiji Kuzuya
, Masatoshi Ishigami
, Takurou Niinomi
, Norihiro Imai
, Kouichi Achiwa
, Takahiro Arakawa
, Keiichi Yamada
, Satoshi Nakano
, Yoji Ishizu
, Takashi Honda
, Kazuhiko Hayashi
, Tetsuya Ishikawa
, Isao Nakano
, Yoshiaki Katano
, Akihiro Itoh
, Yoshiki Hirooka
, Hidemi Goto

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

1 被引用数 (Scopus)

抄録

We investigated the relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma (HCC). Subjects were 64 patients who began sorafenib therapy. Contrast enhanced CT images were taken at baseline and after 2 weeks of sorafenib treatment. In patients with fever, the ratio of patients demonstrating the disappearance or decrease of lesion contrast on contrast enhanced CT images was significantly higher than in those without fever (91.3% and 61.0%, respectively, p=0.010, Fisher's exact probability test). The results suggested the relationship between the fever and contrast change on contrast enhanced CT.

本文言語	英語
ページ（範囲）	505-506
ページ数	2
ジャーナル	Kanzo/Acta Hepatologica Japonica
巻	54
号	7
DOI	https://doi.org/10.2957/kanzo.54.505
出版ステータス	出版済み - 30-05-2013
外部発表	はい

All Science Journal Classification (ASJC) codes

肝臓学

文献へのアクセス

10.2957/kanzo.54.505

他のファイルとリンク

フィンガープリント

「The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Kuzuya, T., Ishigami, M., Niinomi, T., Imai, N., Achiwa, K., Arakawa, T., Yamada, K., Nakano, S., Ishizu, Y., Honda, T., Hayashi, K., Ishikawa, T., Nakano, I., Katano, Y., Itoh, A., Hirooka, Y., & Goto, H. (2013). The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma. Kanzo/Acta Hepatologica Japonica, 54(7), 505-506. https://doi.org/10.2957/kanzo.54.505

@article{41774be1a5c946239feb2801aa9e104e,

title = "The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma",

abstract = "We investigated the relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma (HCC). Subjects were 64 patients who began sorafenib therapy. Contrast enhanced CT images were taken at baseline and after 2 weeks of sorafenib treatment. In patients with fever, the ratio of patients demonstrating the disappearance or decrease of lesion contrast on contrast enhanced CT images was significantly higher than in those without fever (91.3\% and 61.0\%, respectively, p=0.010, Fisher's exact probability test). The results suggested the relationship between the fever and contrast change on contrast enhanced CT.",

keywords = "Fever, Hepatocellular carcinoma, Sorafenib",

author = "Teiji Kuzuya and Masatoshi Ishigami and Takurou Niinomi and Norihiro Imai and Kouichi Achiwa and Takahiro Arakawa and Keiichi Yamada and Satoshi Nakano and Yoji Ishizu and Takashi Honda and Kazuhiko Hayashi and Tetsuya Ishikawa and Isao Nakano and Yoshiaki Katano and Akihiro Itoh and Yoshiki Hirooka and Hidemi Goto",

year = "2013",

month = may,

day = "30",

doi = "10.2957/kanzo.54.505",

language = "English",

volume = "54",

pages = "505--506",

journal = "Kanzo/Acta Hepatologica Japonica",

issn = "0451-4203",

publisher = "Japan Society of Hepatology",

number = "7",

}

Kuzuya, T, Ishigami, M, Niinomi, T, Imai, N, Achiwa, K, Arakawa, T, Yamada, K, Nakano, S, Ishizu, Y, Honda, T, Hayashi, K, Ishikawa, T, Nakano, I, Katano, Y, Itoh, A, Hirooka, Y & Goto, H 2013, 'The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma', Kanzo/Acta Hepatologica Japonica, vol. 54, no. 7, pp. 505-506. https://doi.org/10.2957/kanzo.54.505

The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma. / Kuzuya, Teiji; Ishigami, Masatoshi; Niinomi, Takurou その他.
In: Kanzo/Acta Hepatologica Japonica, Vol. 54, No. 7, 30.05.2013, p. 505-506.

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

TY - JOUR

T1 - The relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma

AU - Kuzuya, Teiji

AU - Ishigami, Masatoshi

AU - Niinomi, Takurou

AU - Imai, Norihiro

AU - Achiwa, Kouichi

AU - Arakawa, Takahiro

AU - Yamada, Keiichi

AU - Nakano, Satoshi

AU - Ishizu, Yoji

AU - Honda, Takashi

AU - Hayashi, Kazuhiko

AU - Ishikawa, Tetsuya

AU - Nakano, Isao

AU - Katano, Yoshiaki

AU - Itoh, Akihiro

AU - Hirooka, Yoshiki

AU - Goto, Hidemi

PY - 2013/5/30

Y1 - 2013/5/30

N2 - We investigated the relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma (HCC). Subjects were 64 patients who began sorafenib therapy. Contrast enhanced CT images were taken at baseline and after 2 weeks of sorafenib treatment. In patients with fever, the ratio of patients demonstrating the disappearance or decrease of lesion contrast on contrast enhanced CT images was significantly higher than in those without fever (91.3% and 61.0%, respectively, p=0.010, Fisher's exact probability test). The results suggested the relationship between the fever and contrast change on contrast enhanced CT.

AB - We investigated the relationship between the fever and the disappearance or decrease of lesion contrast on contrast enhanced CT images after 2 weeks of sorafenib treatment for patients with advanced hepatocellular carcinoma (HCC). Subjects were 64 patients who began sorafenib therapy. Contrast enhanced CT images were taken at baseline and after 2 weeks of sorafenib treatment. In patients with fever, the ratio of patients demonstrating the disappearance or decrease of lesion contrast on contrast enhanced CT images was significantly higher than in those without fever (91.3% and 61.0%, respectively, p=0.010, Fisher's exact probability test). The results suggested the relationship between the fever and contrast change on contrast enhanced CT.

KW - Fever

KW - Hepatocellular carcinoma

KW - Sorafenib

UR - https://www.scopus.com/pages/publications/84940340371

UR - https://www.scopus.com/pages/publications/84940340371#tab=citedBy

U2 - 10.2957/kanzo.54.505

DO - 10.2957/kanzo.54.505

M3 - Article

AN - SCOPUS:84940340371

SN - 0451-4203

VL - 54

SP - 505

EP - 506

JO - Kanzo/Acta Hepatologica Japonica

JF - Kanzo/Acta Hepatologica Japonica

IS - 7

ER -